跳到主要内容

Cytek Biosciences, Inc. (CTKB) Stock Forecast 2025 - AI Price Prediction & Analysis


Cytek Biosciences, Inc. (CTKB) AI Stock Price Forecast & Investment Analysis

Cytek Biosciences, Inc. Stock Price Chart and Technical Analysis

Loading Cytek Biosciences, Inc. interactive price chart and technical analysis...

Cytek Biosciences, Inc. (CTKB) - Comprehensive Stock Analysis & Investment Research

Deep dive into Cytek Biosciences, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Cytek Biosciences, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Cytek Biosciences, Inc.: Cytek Biosciences, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Cytek Biosciences, Inc. (Stock Symbol: CTKB) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry.

The organization employs approximately 555 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Cytek Biosciences, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cytek Biosciences, Inc.: With $196M in annual revenue and -3.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $196 million generating a -3.4% net profit margin .

Market Capitalization: $523 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -1.0% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Cytek Biosciences, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Cytek Biosciences, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Cytek Biosciences, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Cytek Biosciences, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Cytek Biosciences, Inc.: Market positioning analysis based on available financial and operational metrics.

Cytek Biosciences, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 54.9% gross margin, indicating strong pricing power and operational efficiency.

Cytek Biosciences, Inc. (CTKB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Cytek Biosciences, Inc. stock analysis.

Loading Cytek Biosciences, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Cytek Biosciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Cytek Biosciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Cytek Biosciences, Inc.: With a P/E ratio of 82.00, the market highly values future growth prospects.

P/E Ratio 82.00x
P/B Ratio 1.39x
Market Cap $523M
EPS $-0.05
Book Value/Share $2.96
Revenue/Share $1.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Cytek Biosciences, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cytek Biosciences, Inc.: An ROE of -1.0% indicates room for improvement in shareholder value creation.

ROE -1.0%
ROA -0.6%
ROIC -0.4%
Gross Margin 54.9%
Operating Margin -11.8%
Net Margin -3.4%
EBT Margin 1.8%
Tax Rate 69.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Cytek Biosciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Cytek Biosciences, Inc.: A current ratio of 10.26 indicates strong liquidity.

Current Ratio 10.26x
Quick Ratio 9.22x
D/E Ratio 0.03x
Financial Leverage 1.19x
Interest Coverage 2.3x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Cytek Biosciences, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Cytek Biosciences, Inc.: Free cash flow of $-3M indicates cash challenges that need attention.

Operating Cash Flow $1M
Free Cash Flow $-3M
Capital Spending $-5M
FCF/Sales -2.5%
CapEx/Sales 3.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Cytek Biosciences, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Cytek Biosciences, Inc.: An asset turnover of 0.39x suggests room for improvement in asset utilization.

Asset Turnover 0.39x
Receivables Turnover 6.1x
Inventory Turnover 1.7x
Fixed Assets Turnover 12.2x
Days Sales Outstanding 60 days
Days Inventory 217 days
Payables Period 32 days
Cash Conversion Cycle 246 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Cytek Biosciences, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Cytek Biosciences, Inc.: With annual revenue of $196M, Cytek Biosciences, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $196M
R&D Expense $41M
SG&A Expense $37M
Cost of Goods Sold $91M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 90%
Cash & Short-term Investments 75%
Total Liabilities 16%
Short-term Debt 1%
Accounts Receivable 7%
Inventory 8%
Dividend & Shareholder Information
Shares Outstanding 128M
Growth Metrics (YoY)
EPS Growth 0.3%

Latest Cytek Biosciences, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Cytek Biosciences, Inc. (CTKB) stock price and investment outlook.

Cytek Biosciences, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Cytek Biosciences, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast - 30 Days FREE Trial $35123M 28.8x 5.5x
AKYA Unlock Forecast - 30 Days FREE Trial $64M -2.1x -10.9x
ASTC Unlock Forecast - 30 Days FREE Trial $8M 28.9x 0.3x
AVTR Unlock Forecast - 30 Days FREE Trial $8873M 12.9x 1.4x
AXDX Unlock Forecast - 30 Days FREE Trial $0M -0.2x 0.0x
BIO Unlock Forecast - 30 Days FREE Trial $7888M 24.7x 1.1x
BIO-B Unlock Forecast - 30 Days FREE Trial $6816M 21.4x 1.0x
BNGO Unlock Forecast - 30 Days FREE Trial $16M 0.0x 0.3x
BRKR Unlock Forecast - 30 Days FREE Trial $6145M 28.3x 3.2x
CTKB Unlock Forecast - 30 Days FREE Trial $523M 82.0x 1.4x
EYPT Unlock Forecast - 30 Days FREE Trial $923M -4.4x 3.8x
HBIO Unlock Forecast - 30 Days FREE Trial $21M -8.3x 1.4x
ILMN Unlock Forecast - 30 Days FREE Trial $15691M 12.5x 7.0x
LAB Unlock Forecast - 30 Days FREE Trial $519M -2.4x 1.2x
LCTC Unlock Forecast - 30 Days FREE Trial $9M x 1.5x
MTD Unlock Forecast - 30 Days FREE Trial $24913M 31.5x -136.9x
NAUT Unlock Forecast - 30 Days FREE Trial $83M -3.8x 0.5x
OMIC Unlock Forecast - 30 Days FREE Trial $50M -1.7x 0.4x
PACB Unlock Forecast - 30 Days FREE Trial $381M -1.5x 6.2x
PRPO Unlock Forecast - 30 Days FREE Trial $22M -1.2x 0.6x
QTRX Unlock Forecast - 30 Days FREE Trial $209M -11.1x 0.7x
RPID Unlock Forecast - 30 Days FREE Trial $121M -0.9x 2.2x
RVTY Unlock Forecast - 30 Days FREE Trial $10186M 35.7x 1.4x
SEER Unlock Forecast - 30 Days FREE Trial $129M -2.0x 0.4x
TXG Unlock Forecast - 30 Days FREE Trial $1574M -8.6x 2.0x
WAT Unlock Forecast - 30 Days FREE Trial $17631M 26.7x 8.2x

Frequently Asked Questions - Cytek Biosciences, Inc. Stock Forecast

How accurate are Cytek Biosciences, Inc. stock predictions?

Our AI model demonstrates 47% historical accuracy for CTKB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Cytek Biosciences, Inc. stock price forecasts?

Our analysis considers Cytek Biosciences, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Cytek Biosciences, Inc. a good investment in 2025?

Based on our AI analysis, Cytek Biosciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Cytek Biosciences, Inc. forecasts updated?

Cytek Biosciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Cytek Biosciences, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Cytek Biosciences, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...